PT  - JOURNAL ARTICLE
AU  - Nick Wilson
AU  - Lucy Telfar Barnard
AU  - Amanda Kvalsvig
AU  - Ayesha Verrall
AU  - Michael Baker
AU  - Markus Schwehm
TI  - Modelling the Potential Health Impact of the COVID-19 Pandemic on a Hypothetical European Country
AID  - 10.1101/2020.03.20.20039776
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.20.20039776
4099  - http://medrxiv.org/content/early/2020/03/23/2020.03.20.20039776.short
4100  - http://medrxiv.org/content/early/2020/03/23/2020.03.20.20039776.full
AB  - A SEIR simulation model for the COVID-19 pandemic was developed (http://covidsim.eu) and applied to a hypothetical European country of 10 million population. Our results show which interventions potentially push the epidemic peak into the subsequent year (when vaccinations may be available) or which fail. Different levels of control (via contact reduction) resulted in 22% to 63% of the population sick, 0.2% to 0.6% hospitalised, and 0.07% to 0.28% dead (n=6,450 to 28,228).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNilAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the necessary data can be generated by the users themselves since the model is freely available online with a data file export capacity.ParametersNPopulation sizeXNumber of initial infectionstmaxDay after introducti on of the infection when the transmissi on potiential is highestQmaxMaximum isolation capacityTime at which isolation measures startTime at which isolation measures endcHomeFraction of contacts which are prevented for cases who are in home isolationcContFraction of contacts which are preventedTime at which contact reduction startsTime at which contact reduction endsc(t)Fraction of contacts which are reduced at time tyForce of infection which originates fromoutside of the population (e.g. via travellers)R0Average value of the basic reproduction numberaAmplitude of the seasonal fluctuatio n of R0DEAverage duration of the latent periodnENumber of stages for the latent periodεStage transition rate in the latent period (ε = nE / DE)DPAverage duration of the prodoromal periodnPNumber of stages for the prodromal periodφStage transition rate in the prodromal period (φ = nP / DP)iPRelative infectiousness during prodromal periodDIAverage duration of the symptomatic periodnINumber of stages for the symptomatic periodγStage transition rate in the symptomatic period (γ = nI / DI)βI (t)Effective contact rate of individual s in the symptomatic period at time t βI (t) = R0/(iPDP + DI)× (1+ a cos(t / 365))βP (t)Effective contact rate of individual s in the prodromal period at time t (βP (t) = βI (t)iP)pSickFraction of infected individual s who become sickpConsultFraction of sick individual s who seek medical helppHospFraction of sick individual s who are hospitalizedpICUFraction of hospitalized individual s who are admitted to the ICUpDeathFraction of sick individual s who die from the disease